Evidence map›Paper›PMID 30634669›Full record

ReviewMicroorganisms2019

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Simona Buelli, Carlamaria Zoja, Giuseppe Remuzzi, Marina Morigi

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Constipation and hemolytic uremic syndrome.Pediatric nephrology (Berlin, Germany) · 2024
    Article
  7. Platelets in Renal Disease.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Eculizumab Use in a Temporarily Dialysis-Dependent Patient With Shiga Toxin-ProducingThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022
    Article
  12. Article
  13. Toxins · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Atypical hemolytic uremic syndrome: a case report.Journal of medical case reports · 2020
    Article
  18. Treatment Strategies for Infections With Shiga Toxin-ProducingFrontiers in cellular and infection microbiology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Simona BuelliIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy. simona.buelli@marionegri.it.
Carlamaria ZojaIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy. carlamaria.zoja@marionegri.it.
Giuseppe RemuzziIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy. giuseppe.remuzzi@marionegri.it.
Marina MorigiIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy. marina.morigi@marionegri.it.
Mario Negri Institute for Pharmacological Research · ITLuigi Sacco Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin (Stx)-producing

Indexed as

complement alternative pathwayendothelial damagehemolytic uremic syndromelong-term renal sequelaemicrovascular thrombosispodocytesShiga toxin

Identifiers

PMID30634669
PMCPMC6352217
OpenAlexW2909749879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.